Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome (Q33372523)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome
scientific article

    Statements

    Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome (English)
    Raphaèle Seror
    Christelle Sordet
    Eric Hachulla
    Charles Masson
    Sophie Candon
    Véronique Le Guern
    Achille Aouba
    Jean Sibilia
    1 September 2006

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit